Urologie et urogynécologie 11 Minutes Videourodynamic Evaluation: An Introduction for Clinicians Get an introduction to videourodynamic evaluation, including key techniques, clinical... Écrit par Laborie
Urologie et urogynécologie 4 Minutes Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan Effective July 1, 2025, Blue Cross Blue Shield of Michigan... Écrit par Laborie
Urologie et urogynécologie 4 Minutes Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic... Écrit par Laborie
Urologie et urogynécologie 3 Minutes Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and... Écrit par Laborie
Non classifié(e) | Urologie et urogynécologie 3 Minutes Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Écrit par Laborie
Urologie et urogynécologie 3 Minutes Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for... Écrit par Laborie
Urologie et urogynécologie 5 Minutes NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB)... Écrit par Laborie
Urologie et urogynécologie 3 Minutes Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device Laborie Medical Technologies announced a strategic equity investment in Bright... Écrit par Laborie
Non classifié(e) | Urologie et urogynécologie 5 Minutes Laborie Medical Technologies Acquires Urotronic Urotronic joins Laborie as part of a long-term growth strategy... Écrit par Laborie
